Stem Cell Summit

EARLY BIRD DISCOUNT! Register by Mar 01, 2018 to receive 10% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!

registration button

registration button

Subscribe for updates

Dear Colleague,

GTCbio is proud to present the 15th Stem Cell Summit, to be held in Boston, MA. The Stem Cell Summit provides information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. This summit comprises of presentations, panels and round-table discussions to highlight pre-clinical and clinical studies in regenerative medicine, immunotherapy, stem cell reprogramming, cell therapy in diabetes, regulatory policies regarding stem cell research, manufacturing and other relevant topics.

melton douglas - Stem Cell SummitDouglas Melton
Principal Investigator; HHMI
Professor; Harvard University
Keirstead Hans - Stem Cell SummitHans Keirstead 
Chief Executive Officer
AIVITA Biomedical
Snyder Evan - Stem Cell SummitEvan Snyder
Professor and Director, Program in Stem Cell & Regenerative Biology
Sanford-Burnham Medical Research Institute

erin kimbrel

Erin Kimbrel                              Senior Director of Development  Astellas Institute for Regenerative Medicine

The 15th Stem Cell Summit includes two conferences including the joint plenary session:

Joint Sessions:

  1. Plenary Keynote: Historical Perspective and State of the Industry
  2. Round Table Sessions
  3. Lunch Session: Regulatory Challenges in Cell Therapy
  4. Award Ceremony and Closing Keynote Session – Predictions for the Future

Stem Cell Research & Regenerative Medicine:

  1. Advances in Adult Stem Cell Research
  2. Advances in Pluripotent Stem Cell Research
  3. Translation to the Clinic: What’s in the Pipeline
  4. Revolution in Immunotherapy

Stem Cell Product Development & Commercialization:

  1. Stem Cells for Drug Discovery and Disease Modeling
  2. Partnering between Industry, Academia and CROs to Advance Research
  3. Manufacturing and Scalable Processes for Cell Therapy
  4. Funding & Commercialization of Cell Therapy

We hope to see you in Boston!

Best regards,

The 2018 Advisory Committee

2018 Advisory Board Members
Anthony Ting, Athersys
Robert Deans, BlueRock Therapeutics
Douglas Losordo, Caladrius Biosciences
Evan Y. Snyder, Sanford-Burnham Medical Research Institute
Mark Zimmerman, Viacyte
Matthew Durdy, Cell Therapy Catapult
Gil Sambrano, California Institute for Regenerative Medicine
Alain Vertès, NxR Biotechnologies GmbH
Khalid Shah, Harvard Medical School
Satish Medicetty, GTCbio